Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV003258697 | SCV003983480 | uncertain significance | Inborn genetic diseases | 2023-06-23 | criteria provided, single submitter | clinical testing | The c.1363A>G (p.M455V) alteration is located in exon 3 (coding exon 3) of the UBE3A gene. This alteration results from an A to G substitution at nucleotide position 1363, causing the methionine (M) at amino acid position 455 to be replaced by a valine (V). This variant was not reported in population-based cohorts in the Genome Aggregation Database (gnomAD). This amino acid position is well conserved in available vertebrate species. This alteration is predicted to be tolerated by in silico analysis. Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Clinical Molecular Genetics Laboratory, |
RCV000202490 | SCV000257505 | uncertain significance | Autism | 2010-05-20 | no assertion criteria provided | clinical testing |